LnPO4 nanoparticles doped with Ac-225 and sequestered daughters for targeted alpha therapy

Cancer Biotherapy and Radiopharmaceuticals

Volumn 29, Issue 1, 2014, Pages 34-41

  McLaughlin, Mark F ^a,b   Robertson, David ^a   Pevsner, Paul H ^a,c   Wall, Jonathan S ^d   Mirzadeh, Saed ^b   Kennel, Stephen J ^d  

^a UNIVERSITY OF MISSOURI   (United States)

^b OAK RIDGE NATIONAL LABORATORY   (United States)

^c University of Missouri   (United States)

^d UNIVERSITY OF TENNESSEE GRADUATE SCHOOL OF MEDICINE   (United States)

Author keywords

Ac 225; Alpha therapy; Nanoparticle

Indexed keywords

ACTINIUM 225; BISMUTH 213; CITRIC ACID; CLODRONIC ACID; GADOLINIUM; GOLD; IODINE 125; LANTHANIDE PHOSPHATE NANOPARTICLE; LANTHANUM; LIPOSOME; MACROGOL; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 201B; NANOPARTICLE; PHOSPHATE BUFFERED SALINE; SEQUESTERING AGENT; THROMBOMODULIN; UNCLASSIFIED DRUG; ACTINIUM; LANTHANIDE; PHOSPHATE; RADIOPHARMACEUTICAL AGENT;

ALPHA RADIATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY LABELING; ARTICLE; AUTORADIOGRAPHY; CONTROLLED STUDY; DRUG CONJUGATION; ELECTRON MICROSCOPY; IMMUNOHISTOCHEMISTRY; LIMIT OF QUANTITATION; LUNG ALVEOLUS EPITHELIUM; LUNG ALVEOLUS MACROPHAGE; LUNG BLOOD VESSEL; LUNG ENDOTHELIUM; LUNG PARENCHYMA; LUNG TUMOR; MOLECULARLY TARGETED THERAPY; MOUSE; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; REDUCTION KINETICS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TUMOR CELL LINE; ANIMAL; BAGG ALBINO MOUSE; CHEMISTRY; FEMALE; LUNG; METABOLISM; METHODOLOGY; NANOTECHNOLOGY; SCINTISCANNING;

ACTINIUM; ALPHA PARTICLES; ANIMALS; ANTIBODIES, MONOCLONAL; FEMALE; LANTHANOID SERIES ELEMENTS; LUNG; MICE; MICE, INBRED BALB C; NANOPARTICLES; NANOTECHNOLOGY; PHOSPHATES; RADIOPHARMACEUTICALS;

EID: 84890533712     PISSN: 10849785     EISSN: 15578852     Source Type: Journal    
DOI: 10.1089/cbr.2013.1546     Document Type: Article

References (28)

1. Hada M, Georgakilas AG. Formation of clustered DNA damage after high-LET irradiation: A review. J Radiat Res 2008;49:203.
2. Zalutsky MR, Bigner DD. Radioimmunotherapy with aparticle emitting radioimmunoconjugates. Acta Oncol 1996; 35:373.
3. Zalutsky MR, Pozzi OR. Radioimmunotherapy with a-particle emitting radionuclides. Q J Nucl Med Mol Imaging 2004;48:289.
4. Sgouros G, Ballangrud AM, Jurcic JG, et al. Pharmacokinetics and dosimetry of an a-particle emitter antibody: 213Bi-HuM195 (anti-CD33) in patients with leukemia. J Nucl Med 1999;40:1935.
5. Kim Y, Brechbiel MW. An overview of targeted alpha therapy. Tumor Biol 2012;33:573.
6. Crawford ED, Flaig TW. Optimizing outcomes of advanced prostate cancer: Drug sequencing and novel therapeutic approaches. Oncology 2012;26:70.
7. Dahle J, Borrebæk MKB, Bruland ØS, et al. Initial evaluation of 227Th-p-benzyl-DOTA-rituximab for low-dose rate aparticle radioimmunotherapy. Nucl Med Biol 2006;33:271.
8. Larsen RH, Borrebæk J, Dahle J, et al. Preparation of 227Thlabeled radioimmunoconjugates, assessment of serum stability and antigen binding ability. Cancer Biother Radiopharm 2007;22:431.
9. McDevitt MR, Ma D, Lai LT, et al. Tumor therapy with targeted atomic nanogenerators. Science 2001;294:1537.
10. Jaggi JS, Kappel BJ, McDevitt MR, et al. Efforts to control the errant products of a targeted in vivo generator. Cancer Res 2005;65:4888.
11. Sofou S, Thomas JL, Lin H, et al. Engineered liposomes for potential {alpha}-particle therapy of metastatic cancer. Nucl Med 2004;45:253.
12. Chang M, Seideman J, Sofou S. Enhanced loading efficiency and retention of 225Ac in rigid liposomes for potential targeted therapy of micrometastases. Bioconj. Chem 2008;19: 1274.
13. Thijssen L, Schaart DR, de Vries D, et al. Polymersomes as nano-carriers to retain harmful recoil nuclides in alpha radionuclide therapy: A feasibility study. Radiochim Acta 2012;100:473.
14. Mwakisege J, Mirzadeh S, Boll RA, et al. Synthesis and chemical stability of actinium-fullerenes. Presented at the 234th American Chemical Society National Meeting, Boston, MA, 2007.
15. Woodward J, Kennel SJ, Stuckey A, et al. LaPO4 nanoparticles doped with actinium-225 that partially sequester daughter radionuclides. Bioconj Chem 2011;22:776.
16. McLaughlin MF, Woodward J, Boll RA, et al. Gold coated lanthanide phosphate nanoparticles for targeted alpha generator radiotherapy. Plos One 2013;8:e54531.
17. McLaughlin MF, Woodward J, Boll RA, et al. Gold-coated lanthanide phosphate nanoparticles for an 225Ac in vivo alpha generator. Radiochim Acta 2013;101:595.
18. Boll RA, Malkemus D, Mirzadeh S. Production of actinium- 225 for alpha particle mediated Therapy. Radiochim Acta 2005;79:145.
19. Love JC, Estroff LA, Jennah KK, et al. Self-assembled monolayers of thiolates on metals as a form of nanotechnology. Chem Rev 2005;105:1103.
20. Kennel SJ, Huang Y, Zeng WB, et al. Kinetics of vascular targeted monoclonal antibody. Curr Drug Deliv 2010;7:428.
21. Kennel SJ, Woodward JD, Rondinone AJ, et al. The fate of targeted Cd125mTe/Zns nanoparticles in vivo. Nucl Med Biol 2008;35:501.
22. Wall J, Richey T, Williams A, et al. Comparative analysis of peptide p5 and serum amyloid P component for imaging AA amyloid in mice using dual-isotope SPECT. Mol Imaging and Biol 2012;14:402.
23. Kennel SJ, Chappell LL, Dadachova K, et al. Evaluation of 225Ac for vascular targeted radioimmunotherapy of lung tumors. Cancer Biother Radiopharm 2000;15:235.
24. Kennel SJ, Lankford TK, Foote LJ, et al. CD44 expression on murine tissues. J Cell Sci 1993;104:373.
25. Kennel SJ, Lee R, Bultman S, et al. Rat monoclonal-antibody distribution in mice-An epitope inside the lung vascular space mediates very efficient localization. Nucl Med Biol 1990;17:193.
26. Kennel SJ, Boll R, Stabin M, et al. Radioimmunotherapy of micrometastases in lung with vascular targeted 213Bi. Br J Cancer 1999;80:175.
27. Kennel SJ, Mirzadeh S, Eckleman WC, et al. Vascular targeted radioimmunotherapy with the a emitter 211At. Radiat Res 2002;157:633.
28. Blumenthal RD, Sharkey RM, Haywood L, et al. Targeted therapy of athymic mice bearing GW-39 human colonic cancer micrometastases with 131I-labeled monoclonal antibodies. Cancer Res 1992;52:6036.